These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 15449549
1. [Effects of acute octreotide infusion on renal function in patients with cirrhosis and portal hypertension]. Silva G, Segovia R, Backhouse C, Palma M, Márquez S, Iturriaga H. Rev Med Chil; 2004 Feb; 132(2):144-50. PubMed ID: 15449549 [Abstract] [Full Text] [Related]
2. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial. Ottesen LH, Aagaard NK, Kiszka-Kanowitz M, Rehling M, Henriksen JH, Pedersen EB, Flyvbjerg A, Bendtsen F. Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531 [Abstract] [Full Text] [Related]
5. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Escorsell A, Bandi JC, Andreu V, Moitinho E, García-Pagán JC, Bosch J, Rodés J. Gastroenterology; 2001 Jan; 120(1):161-9. PubMed ID: 11208725 [Abstract] [Full Text] [Related]
8. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A. Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229 [Abstract] [Full Text] [Related]
9. [Splanchnic hemodynamic effects of somatostatin and octreotide in cirrhotic patients. A Doppler ultrasonographic study]. Fernández Pérez FJ, Jiménez Sáenz M, García Montes JM, Rebollo Bernárdez J, Herrerías Gutiérrez JM. Rev Esp Enferm Dig; 2008 Sep; 100(9):552-9. PubMed ID: 19025306 [Abstract] [Full Text] [Related]
10. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects. Morillas RM, Planas R, Cabré E, Galán A, Quer JC, Feu F, García Pagán JC, Bosch J, Gassull MA. Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651 [Abstract] [Full Text] [Related]
13. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension. Gatta A, Sacerdoti D, Merkel C, Milani L, Battaglia G, Zuin R. Am Heart J; 1984 Oct; 108(4 Pt 2):1167-72. PubMed ID: 6148880 [Abstract] [Full Text] [Related]
20. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. Hwang SJ, Lin HC, Chang CF, Lee FY, Lu CW, Hsia HC, Wang SS, Lee SD, Tsai YT, Lo KJ. J Hepatol; 1992 Nov; 16(3):320-5. PubMed ID: 1487608 [Abstract] [Full Text] [Related] Page: [Next] [New Search]